In accordance with observations in solid cancer, miR-193b exhibits tumor suppressing effects in acute myeloid leukemia and T-cell acute lymphatic leukemia through suppression of c-kit and Myb, respectively [27,28]. Here, MYB is linked to acute myeloid leukemia.